Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Afya's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Afya's regulatory disclosures and financial reporting.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of Class A Common Shares. He sold 1,510 shares at $14.91 per share on March 30, 2026 and 300 shares at $15.00 per share on March 27, 2026, totaling 1,810 shares sold.
After these transactions, he directly holds 151,938 Class A Common Shares. In addition, 200,000 Class A Common Shares are held indirectly through GIBBOAT OVERSEAS LTD, which is solely owned and controlled by him, indicating a substantially larger remaining overall position.
XP Investments US, LLC submitted a Form 144 disclosing an intended sale of Class A common shares of Afya Limited.
The filing lists securities acquired under compensation plans: 36,000 shares acquired pursuant to an S-8 stock option plan on 04/25/2025 and 7,032 shares from a Restricted Share Units program on 05/01/2025.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of Class A common shares. On March 25, 2026, he sold 3,900 shares at $15.18 per share, and on March 26, 2026 he sold 800 shares at $15.21 per share, totaling 4,700 shares sold. After these transactions, he directly holds 153,748 Class A shares and indirectly holds 200,000 Class A shares through GIBBOAT OVERSEAS LTD, which is solely owned and controlled by him.
AFYA submitted a Form 144 notice proposing the sale of Class A common shares. The filing lists planned sale activity tied to equity compensation events, with representative entries including 23,500 and 14,051 shares acquired under company plans on 06/10/2025 and 05/01/2025.
The excerpt ties the shares to stock option and restricted share unit programs and reports transaction dates; timing and aggregate offer amount are not stated in the provided excerpt.
Afya Ltd director Esteves Nicolau Carvalho has amended his insider holdings disclosure. The Form 3/A restates his positions without reporting any new purchases or sales. He now reports indirect ownership, through NRE Capital Ventures Ltd., of 4,500,000 Class B common shares, each linked to 4,500,000 underlying Class A common shares, plus 5,321,379 Class A common shares, and direct ownership of 13,916 Class A common shares.
The amendment clarifies that NRE Capital Ventures Ltd. is owned by Carvalho and his wife, Rosangela Esteves, correcting an earlier filing that had described him as the sole owner and controller.
Afya Ltd vice president Junior Lelio de Souza has filed an initial statement of equity holdings. The filing lists stock options over 8,000 Class A common shares per grant at an exercise price of 52.0000 or 62.5900, with expiration dates from 2026 through 2033. Footnotes state these options fully vest and become exercisable three years before each expiration date, subject to continued service.
The filing also shows restricted stock units over 20,000 and 29,400 Class A common shares, which are scheduled to vest in tranches between May 1, 2026 and May 1, 2029, again conditioned on continued service. In addition, he directly holds 43,032 Class A common shares.
Afya Ltd Vice President Basolli Gomiero Mirella filed an initial ownership report showing a mix of common shares, stock options and restricted stock units tied to Class A Common Shares.
The filing lists four stock option grants, each labeled as a right to buy 26,000 Class A Common Shares at an exercise price of 59.4700 (denominated in Brazilian Reais), with expirations on May 1, 2028, May 1, 2029, May 1, 2030 and May 1, 2031. According to the footnotes, these options fully vest and become exercisable three years before their respective expiration dates, subject to continued service.
The report also shows 29,820 Class A Common Shares subject to outstanding RSUs, which are scheduled to vest as to 12,780 shares on May 1, 2026 and 17,040 shares on May 1, 2027, again contingent on continued service. In addition, the Vice President directly holds 35,265 Class A Common Shares as of the reporting date.
Afya Ltd director Marcelo Ken Suhara filed an initial Form 3 reporting his beneficial ownership position in the company. The available data shows no reported transactions, derivative positions, or specific share holdings at this time, indicating this is a baseline regulatory ownership disclosure rather than an active trade report.
Afya Ltd executive Denis Del Bianco, a Vice President, reported his existing equity interests in the company. The filing shows multiple stock option grants over Class A common shares with exercise prices of 62.5900 and 52.0000 (denominated in Brazilian Reais) and staggered vesting and expiration dates through 2033. It also lists several restricted stock unit awards over 35,000, 3,200 and 15,200 Class A shares that vest between 2026 and 2029, plus 9,545 Class A common shares held directly.
Afya Ltd director Joao Paulo Seibel de Faria has filed an initial insider ownership report with no transactions disclosed. The filing shows no reported purchases, sales, exercises, gifts, tax withholdings, restructurings, or derivative positions, serving mainly as a baseline registration of his status as a director.